ArticleBMC endocrine disorders2026
State transitions and related factors of type 2 diabetes based on multi-state Markov model among a Chinese health check-up cohort.
Article in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundTo explore the transitions of different blood glucose states based on a multi-state Markov model among the Chinese health check-up population.
methodsIn this research, the multi-state Markov model was built based on 4776 blood glucose status assessments in 1677 Chinese participants. A quantitative longitudinal study was conducted to explore diabetes progression, providing information on the transition probability, the sojourn time, and the risk factors in three blood glucose states, namely normal (state 1), prediabetes (state 2), and diabetes (state 3).
resultsAmong 4776 transition cases, there were 318 cases (6.7%) with remission (state 2→1), 3505 cases (73.4%) with stable disease (state 1→1, 2→2, 3→3), and 953 cases (19.9%) with progressive disease (state 1→2, 1→3, 2→3). The probability of progression from normal state to diabetes was 1.1% within 1 year and increased to 11.9% within 6 years. Increased age, blood pressure, and body mass index were risk factors for progression to diabetes in the normal state or prediabetes.
conclusionsThis article serves as a reference for targeted interventions for diabetes progression among the Chinese health check-up population. Obesity, hypertension and hyperlipidemia are risk factors that worsen the progression of diabetes, and preventive actions should be taken at an early stage. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.